Back to REGN
Creative Planning REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
10
Latest value
$44.8M
Q3 2026
Peak value
$44.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $11.1M |
| Q3 2025 | $123K |
| Q4 2025 | $23M |
| Q4 2025 | $222K |
| Q1 2026 | $289K |
| Q1 2026 | $30.7M |
| Q2 2026 | $230K |
| Q2 2026 | $22.8M |
| Q3 2026 | $410K |
| Q3 2026 | $44.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $44.8M | 59.1K | — | — |
| Q3 2026 | $410K | 540 | — | — |
| Q2 2026 | $22.8M | 36.6K | — | — |
| Q2 2026 | $230K | 368 | — | — |
| Q1 2026 | $30.7M | 39.8K | — | — |
| Q1 2026 | $289K | 374 | — | — |
| Q4 2025 | $222K | 287 | — | — |
| Q4 2025 | $23M | 29.8K | — | — |
| Q3 2025 | $123K | 218 | — | — |
| Q3 2025 | $11.1M | 19.7K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B